An ecological study of determinants of coronary heart disease rates: A comparison of Czech, Bavarian and Israeli men

International Journal of Epidemiology

Volumn 28, Issue 3, 1999, Pages 437-444

  Bobak, Martin ^a   Hense, Hans Werner ^d   Kark, Jeremy ^b   Kuch, Bernhard ^d   Vojtisek, Petr ^c   Sinnreich, Ronit ^d   Gostomzyk, Johannes ^d   Bui, Mai ^d   Von Eckardstein, Arnold ^d   Junker, Ralf ^d   Fobker, Manfred ^d   Schulte, Helmut ^d   Assmann, Gerd ^d   Marmot, Michael ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c City Hospital   (Czech Republic)

^d NONE

Author keywords

Cardiovascular disease rates; Carotenoids; Coagulation factors; Eastern Europe; Ecological study; Homocysteine; Risk factors

Indexed keywords

ALPHA CAROTENE; BETA CAROTENE; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; LYCOPENE; RETINOL; TOCOPHEROL;

COMPARATIVE STUDY; DISEASE PREVALENCE; INTERNATIONAL COMPARISON; MEDICAL GEOGRAPHY;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CITY; CZECH REPUBLIC; DIABETES MELLITUS; GERMANY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; ISRAEL; LIFESTYLE; MALE; MEAN ARTERIAL PRESSURE; MEDICAL EXAMINATION; MORTALITY; NORMAL HUMAN; OBESITY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; TRIACYLGLYCEROL BLOOD LEVEL;

ASIA; BIOLOGY; CARDIOVASCULAR EFFECTS; CAUSES OF DEATH; COMPARATIVE STUDIES; CROSS-CULTURAL COMPARISONS; CZECH REPUBLIC; DEMOGRAPHIC FACTORS; DEVELOPED COUNTRIES; DIET; DIFFERENTIAL MORTALITY; DISEASES; EASTERN EUROPE; EUROPE; GERMANY; HEALTH; HEART DISEASES; ISRAEL; MEDITERRANEAN COUNTRIES; MORTALITY; NUTRITION; PHYSIOLOGY; POPULATION; POPULATION DYNAMICS; RESEARCH METHODOLOGY; STUDIES; WESTERN ASIA; WESTERN EUROPE;

AGED; BLOOD GLUCOSE; BLOOD PRESSURE; CORONARY DISEASE; CZECHOSLOVAKIA; FIBRINOGEN; GERMANY; HOMOCYSTEINE; HUMANS; ISRAEL; LIPOPROTEINS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; TRIGLYCERIDES;

CZECH REPUBLIC; GERMANY; ISRAEL;

EID: 0033042120     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/28.3.437     Document Type: Article

References (41)

1. Bobak M, Marmot M. East-west mortality divide and its potential explanations: proposed research agenda. Br Med J 1996;312:421-25.
2. Bosma H, Appels A, Sturmans R, Grabauskas V, Gostautas A. Differences in mortality and coronary heart disease between Lithuania and the Netherlands: results from the WHO Kaunas-Rotterdam Intervention Study (KRIS). Int J Epidemiol 1994;23:12-19.
3. Logan RL, Riemersma RA, Thomson M, Oliver MF et al. Risk factors for ischaemic heart disease in normal men aged 40. Edinburgh-Stockholm study. Lancet 1978;i:949-55.
4. The World Health Organization MONICA Project. Ecological analysis of the association between mortality and major risk factors of cardiovascular disease. Int J Epidemiol 1994;23:505-16.
5. Kristenson M, Zieden B, Kucinskiene Z et al. Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: concomitant cross-sectional study of men aged 50. Br Med J 1997;314:629-33.
6. Bobak M, Feachem RGA. Health status in the Czech and Slovak Federal Republic. Health Policy Planning 1992;7:234-42.
7. WHO MONICA Project, Tunstall-Pedoe H, Kuulasmaa K et al. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612.
8. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods. Geneva: World Health Organization, 1982.
9. Eckert S, Gleichmann S, Gleichmann U. Validierung von Blutdruck-Selbstmessgeräten. In. Gleichmann S, Eckert S, Gleichmann U, Vetter W (eds). Blutdruckselbstmessung. Darmstadt: Steinkopff, 1994, pp. 37-51.
10. Bui MH. Simple determination of retinol, alpha-tocopherol and carotenoids (lutein, all-trans-lycopene, alpha- and beta-carotenes) in human plasma by isocratic liquid chromatography. J Chromatogr B Biomed Appl 1994;654:129-33.
11. Utermann G. The mysteries of lipoprotein(a). Science 1989;246:904-10.
12. Rose G. The Strategy of Preventive Medicine. Oxford: Oxford University Press, 1992.
13. Duncan MH, Singh BM, Wise PH, Carter G, Alaghband-Zadeh J. A simple measure of insulin resistance [Letter]. Lancet 1995;346: 120-21.
14. Ernst E. The role of fibrinogen as a cardiovascular risk factor. Atherosclerosis 1993;100:1-12.
15. Heinrich J, Balleisen L, Schulte H, Assmann G, Van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Results of the PROCAM study in healthy men. Arterioscler Thrombo 1994;14: 54-59.
16. Ridker PM, Hennekens CH, Cerkus A, Stampfer M. Plasma concentrations of cross-linked fibrin degradation products (D-Dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation 1994;90:2236-40.
17. Meade TW, Mellows S, Brozovic M et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986;ii:533-37.
18. Junker R, Heinrich J, Schulte H, Van de Loo J, Assmann G. Coagulation factor VII and the risk of coronary heart disease in health men. Arterioscl Thromb Vasc Biol 1997;17:1539-44.
19. Alfthan G, Aro A, Gey KF. Plasma homocysteine and cardiovascular disease mortality. Lancet 1997;349:397.
20. Stampfer MJ, Malinow R, Willett WC et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 1992;268:877-81.
21. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274:1049-57.
22. Graham IM, Daly LE, Refsum HM et al. Plasma homocysteine as a risk factor for vascular disease. JAMA 1997;277:1775-81.
23. Zino A, Skeaff M, Williams S, Mann J. Randomised controlled trial of effect of fruit and vegetable consumption on plasma concentrations of lipids and antioxidants. Br Med J 1997;314:1787-91.
24. Di Mascio P, Murphy ME, Sies H. Antioxidant defence systems: the role of carotenoids, tocopherols, and thiols. Am J Clin Nutr 1991;53 Suppl:194S-200S.
25. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344:793-95.
26. Kardinaal AFM, Kok JF, Ringstad J et al. Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC study. Lancet 1993;342:1379-84.
27. Street DA, Comstock GW, Salkeld RM, Schuep W, Klag M. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction? Circulation 1994;90:1154-61.
28. Kohlmeir L, Kark JD, Gomez-Gracia E et al. Lycopene and myocardial infarction risk in the EURAMIC Study. Am J Epidemiol 1997;146: 618-26.
29. The Alpha-Tocopherol Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330:1029-35.
30. Hennekens CH, Buring JE, Manson JE et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334: 1145-49.
31. Omenn GS, Goodman GE, Thornquist MD et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-55.
32. Greenberg ER, Sporn MB. Antioxidant vitamins, cancer, and cardio-vascular disease. N Engl J Med 1996;334:1189-90.
33. Ginter E. High cardiovascular mortality in postcommunist countries: participation of oxidative stress? Int J Vit Nutr Res 1996;66:183-89.
34. Trichopoulou A, Lagiou P (eds). Methodology for the Exploitation of Household Budget Survey Food Data and Results on Food Availability in Five European Countries (Cost Action 99 DAFNE Project Report). Brussels: European Commission, 1997.
35. Powles JW, Day NE, Sanz MA, Bingham SA. Protective foods in winter and spring: a key to lower vascular mortality? Lancet 1996; 348:898-99.
36. Gjonca A, Bobak M. Albanian paradox, another example of protective effect of Mediterranean lifestyle? Lancet 1997;350:1815-17.
37. EURONUT-SENECA. Nutrition and the elderly in Europe. Eur J Clin Nutr 1991;45(Suppl.3):1-165.
38. Bobak M, Brunner E, Miller NJ, Skodova Z, Marmot M. Could anti-oxidants play a role in the high rates of coronary heart disease in the Czech Republic? Eur J Clin Nutr 1998;52:632-36.
39. Bobak M, Skodova Z, Pisa Z, Poledne R, Marmot M. Political changes and trends in cardiovascular risk factors in the Czech Republic 1985-1992. J Epidemiol Community Health 1997;51:272-77.
40. Zatonski WA, McMichael AJ, Powles JW. Ecological study of reasons for sharp decline in mortality from ischaemic heart disease in Poland since 1991. Br Med J 1998;316:1047-51.
41. McKeigue PM, Marmot MG, Adelstein AM et al. Diet and risk factors for coronary heart disease in Asians in northwest London. Lancet 1985;2:1086-90.